Becton Dickinson and Co (BDX) Position Raised by Buckingham Asset Management LLC

Buckingham Asset Management LLC increased its position in shares of Becton Dickinson and Co (NYSE:BDX) by 5.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,962 shares of the medical instruments supplier’s stock after purchasing an additional 342 shares during the period. Buckingham Asset Management LLC’s holdings in Becton Dickinson and were worth $1,817,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Ascension Asset Management LLC increased its position in shares of Becton Dickinson and by 4.2% during the second quarter. Ascension Asset Management LLC now owns 4,970 shares of the medical instruments supplier’s stock valued at $1,191,000 after acquiring an additional 200 shares during the last quarter. Bfsg LLC increased its position in shares of Becton Dickinson and by 1.9% during the second quarter. Bfsg LLC now owns 10,515 shares of the medical instruments supplier’s stock valued at $2,519,000 after acquiring an additional 201 shares during the last quarter. Toth Financial Advisory Corp increased its position in shares of Becton Dickinson and by 0.8% during the second quarter. Toth Financial Advisory Corp now owns 24,989 shares of the medical instruments supplier’s stock valued at $5,986,000 after acquiring an additional 203 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its position in shares of Becton Dickinson and by 0.4% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 50,849 shares of the medical instruments supplier’s stock valued at $12,181,000 after acquiring an additional 204 shares during the last quarter. Finally, Spearhead Capital Advisors LLC increased its position in shares of Becton Dickinson and by 1.4% during the third quarter. Spearhead Capital Advisors LLC now owns 15,525 shares of the medical instruments supplier’s stock valued at $3,887,000 after acquiring an additional 218 shares during the last quarter. Hedge funds and other institutional investors own 92.60% of the company’s stock.

Shares of BDX stock opened at $237.32 on Tuesday. The company has a quick ratio of 0.81, a current ratio of 1.23 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $63.03 billion, a P/E ratio of 25.03, a price-to-earnings-growth ratio of 1.40 and a beta of 1.19. Becton Dickinson and Co has a fifty-two week low of $209.91 and a fifty-two week high of $265.87.

BDX has been the subject of a number of recent analyst reports. KeyCorp reiterated a “buy” rating and set a $264.00 price target on shares of Becton Dickinson and in a research report on Friday, August 3rd. Royal Bank of Canada reiterated a “hold” rating and set a $248.00 price target on shares of Becton Dickinson and in a research report on Friday, August 3rd. Citigroup lifted their price target on shares of Becton Dickinson and from $274.00 to $283.00 and gave the company a “buy” rating in a research report on Wednesday, August 8th. Wells Fargo & Co lifted their price target on shares of Becton Dickinson and from $275.00 to $290.00 and gave the company an “outperform” rating in a research report on Thursday, September 6th. They noted that the move was a valuation call. Finally, Morgan Stanley lifted their price target on shares of Becton Dickinson and from $250.00 to $280.00 and gave the company an “equal weight” rating in a research report on Thursday, October 4th. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Becton Dickinson and has an average rating of “Buy” and a consensus target price of $256.14.

COPYRIGHT VIOLATION NOTICE: “Becton Dickinson and Co (BDX) Position Raised by Buckingham Asset Management LLC” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/11/06/becton-dickinson-and-co-bdx-position-raised-by-buckingham-asset-management-llc.html.

Becton Dickinson and Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems.

Featured Story: Cash Flow Analysis in Stock Selection

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply